What does neuromodulation — foreign currency adjustments mean?

Reflects the impact of exchange rate fluctuations on the financial results of the Neuromodulation segment's international operations. This metric helps isolate operational performance from the volatility of global currency markets.

LivaNova (LIVN) Neuromodulation — Foreign currency adjustments

Screener

Other segment segments

Cardiopulmonary

-$6.45M-120%

Similar metrics at other companies

FISBanking Solutions — Foreign currency adjustments

-$46M-356%

FISCapital Market Solutions — Foreign currency adjustments

-$23M-156%

FISCorporate and Other — Foreign currency adjustments

$0—

WTFCCommunity Banking — Foreign Currency Adjustments

-$11.33M—

WTFCSpecialty finance — Foreign Currency Adjustments

$10.89M+799%

WTFCWealth management — Foreign Currency Adjustments

$0—

Other financials

Income statement

See full

Revenue$390.6M+10.8%

Gross profit$273.7M+14.5%

Operating income$49.5M-8.7%

Net income$108.6M+300%

EPS (diluted)$1.93+286%

Balance sheet

See full

Cash & equivalents$516.6M-13.0%

Total debt$348.5M-27.8%

Total equity$1.3B+18.0%

Total assets$2.6B+5.4%

Cash flow

See full

Operating cash flow$66.6M+5.8%

CapEx$31.6M+108%

Free cash flow$35.0M-26.7%

Valuation

See full

Market cap$4.17B+61.5%

Enterprise value$4.01B+61.9%

P/E22.6×-67.9×

P/S2.8×+0.9×

Profitability

See full

Gross margin68.1%+0.1pp

Operating margin12.7%-0.7pp

Net margin-16.1%-18.0pp

FCF margin10.1%-2.3pp

Returns & leverage

See full

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.2×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed: Aug 5, 2026, 2:23 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001639691-26-000090

Line item	Cardiopulmonary	Neuromodulation	Total
December 31, 2025	$394,086	$398,754	$792,840
Foreign currency adjustments	(13,696)	—	(13,696)
June 30, 2026	$380,390	$398,754	$779,144

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's neuromodulation — foreign currency adjustments?: LivaNova (LIVN) reported neuromodulation — foreign currency adjustments of $0 in Q2 2026.
What does neuromodulation — foreign currency adjustments mean?: Reflects the impact of exchange rate fluctuations on the financial results of the Neuromodulation segment's international operations. This metric helps isolate operational performance from the volatility of global currency markets.